Healthcare IT Today
AUGUST 1, 2023
This funding empowers Parker Health to further its position as the industry’s most compliant and competitive solution helping expand our medical technology and services and to employ global teams. Parker Health has raised $26.3 million to date.
Lloyd Price
MAY 5, 2024
Dedicated Facilities: The new EIT Oxford campus includes over 30,000 square meters of research laboratory space, an oncology and wellness clinic, and facilities like AI GPU Supercluster Lab, Drug Design Lab, and Medical Device Lab, specifically dedicated to healthcare technology advancements. Visit www.nelsonadvisors.co.uk
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
MARCH 16, 2023
We believe our pioneering technology will allow us to shatter the boundaries that exist in gene editing methods today,” said Anne-K. Both Wellington and Forbion are visionaries and highly experienced biotech investors, and we look forward to working closely with them in our efforts to transform the gene editing landscape.” “Our
Healthcare Innovation Consortium
OCTOBER 24, 2023
We aim to bring together relevant stakeholders, including payers, providers, patients groups, and biotech and when and where needed we cooperate with pharma, to be the one voice of the industry. Inna: Our aim is to improve patient and clinician access to modern, innovative and reliable medical technology.
Health Populi
JANUARY 8, 2019
Digging deeper into some of the big trends, Shelly’s observations will also ring authentic to health/care stakeholders… AI is everywhere at CES. As my friends at #JPM this week are hearing in San Francisco, AI is part of virtually every biotech and med-tech story. But it’s not necessarily useful for everything.
Digital Health Global
FEBRUARY 5, 2024
Through its AI-based, non-invasive arrhythmia analysis technology, vMap, the company aims to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency. TVM also invests in differentiated commercial-stage medical technologies and late clinical-stage therapeutics.
Lloyd Price
FEBRUARY 24, 2019
One of the biggest challenges involves efficiently achieving validations of digital health devices and smartphone apps – that is, ensuring the intended use of a medical device and the management of its data. Loetitia Jabri is regulatory, pharmaceutical & medical devices platforms associate director at ProductLife Group.
Expert insights. Personalized for you.
52 
Let's personalize your content